Loading company data...

Director, US Marketing, Inborn Errors of Metabolism
Ultragenyx
Novato, CA (Remote)

Brand
Loading company data...
Company growth over the last 12 months
Total funding
$1.5B
Last raise
$400M
Post IPO Debt, 4 months ago
Funding history
Nov 2025
Post IPO Debt Ultragenyx Pharmaceutical · $400M
Jun 2024
Post IPO Equity Ultragenyx Pharmaceutical · $350M
Oct 2023
Post IPO Equity Ultragenyx Pharmaceutical · $300M
Feb 2019
Post IPO Equity Ultragenyx Pharmaceutical · $304.3M
Jun 2016
Post IPO Equity Ultragenyx Pharmaceutical · $65M
Loading insights...
Dec 2012
Series B Ultragenyx Pharmaceutical · $75M
LinkedIn followers
Follower count and growth
Total followers
107.8K
12-mo growth
+22.5%
Monthly growth
+2.2%
Typical salary range
$187,100 – $231,200
/ yrHelp build salary transparency at Ultragenyx
Share your compensation anonymously to see full data.
Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.
Shows if the company is growing, flat, or shrinking.
Shows a quick risk view from growth, funding age, and news.
Shows traffic size, change, and traffic sources.
Shows competitors and key search metrics in one view.
Shows follower count and growth.
LinkedIn followers
Follower count and growth
Shows if the marketing team is growing, flat, or shrinking.
Shows saved Glassdoor ratings.
Shows saved funding data.
Shows saved company news.
Total followers
107.8K
12-mo growth
+22.5%
Monthly growth
+2.2%

Ultragenyx
Novato, CA (Remote)

Ultragenyx
Novato, CA (Remote)

Ultragenyx
Novato, CA (Remote)

Ultragenyx
Novato, CA (Remote)

Ultragenyx
USA (Remote)